IL229242B - חיסון תאי אלוגנאי לסרטן - Google Patents

חיסון תאי אלוגנאי לסרטן

Info

Publication number
IL229242B
IL229242B IL229242A IL22924213A IL229242B IL 229242 B IL229242 B IL 229242B IL 229242 A IL229242 A IL 229242A IL 22924213 A IL22924213 A IL 22924213A IL 229242 B IL229242 B IL 229242B
Authority
IL
Israel
Prior art keywords
tumor cell
allogeneic tumor
cell vaccination
vaccination
allogeneic
Prior art date
Application number
IL229242A
Other languages
English (en)
Other versions
IL229242A0 (he
Inventor
Tamar Peretz
Michal Lotem
Arthur Machlenkin
Shoshana Frankenburg
David Inna Ben
Anna Kunzetz
Yael Gelfand
Galit Eisenberg
Yhahana Merav Darash
Original Assignee
Tamar Peretz
Michal Lotem
Arthur Machlenkin
Shoshana Frankenburg
David Inna Ben
Anna Kunzetz
Yael Gelfand
Galit Eisenberg
Yhahana Merav Darash
Hadasit Med Res Service
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IL2012/000197 external-priority patent/WO2012156969A1/en
Application filed by Tamar Peretz, Michal Lotem, Arthur Machlenkin, Shoshana Frankenburg, David Inna Ben, Anna Kunzetz, Yael Gelfand, Galit Eisenberg, Yhahana Merav Darash, Hadasit Med Res Service filed Critical Tamar Peretz
Priority to IL229242A priority Critical patent/IL229242B/he
Publication of IL229242A0 publication Critical patent/IL229242A0/he
Publication of IL229242B publication Critical patent/IL229242B/he

Links

IL229242A 2011-05-17 2013-11-04 חיסון תאי אלוגנאי לסרטן IL229242B (he)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL229242A IL229242B (he) 2011-05-17 2013-11-04 חיסון תאי אלוגנאי לסרטן

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161487218P 2011-05-17 2011-05-17
US201161501797P 2011-06-28 2011-06-28
PCT/IL2012/000197 WO2012156969A1 (en) 2011-05-17 2012-05-17 Allogeneic tumor cell vaccination
IL229242A IL229242B (he) 2011-05-17 2013-11-04 חיסון תאי אלוגנאי לסרטן

Publications (2)

Publication Number Publication Date
IL229242A0 IL229242A0 (he) 2014-01-30
IL229242B true IL229242B (he) 2019-09-26

Family

ID=50023001

Family Applications (1)

Application Number Title Priority Date Filing Date
IL229242A IL229242B (he) 2011-05-17 2013-11-04 חיסון תאי אלוגנאי לסרטן

Country Status (1)

Country Link
IL (1) IL229242B (he)

Also Published As

Publication number Publication date
IL229242A0 (he) 2014-01-30

Similar Documents

Publication Publication Date Title
SG11201504219QA (en) Recipient for cell cultivation
SG11201503579RA (en) Cell culture med
SG10201700670WA (en) Cell culture
SG11201500396TA (en) Tumor vaccination
IL231043A0 (he) תרכיב
GB201003293D0 (en) Cancer vaccine
ZA201502595B (en) Therapeutic methods
GB201119999D0 (en) Vaccine
SI3536334T1 (sl) Cepiva proti raku, ki ciljajo na rakave matične celice
ZA201402071B (en) Vaccine therapy
ZA201306245B (en) Combination vaccines
PL2591798T3 (pl) Szczepionka do zastosowania w immunoterapii nowotworów
EP3536340B8 (en) Autologous cancer cell vaccine
GB201211873D0 (en) Cell culture
GB201120000D0 (en) Vaccine
IL229242B (he) חיסון תאי אלוגנאי לסרטן
GB201102913D0 (en) Novel therapeutic
GB201107549D0 (en) Cancer vaccine
GB201109294D0 (en) Novel vaccine
GB201120096D0 (en) Novel therapy
GB201108982D0 (en) Vaccines
GB201108984D0 (en) Vaccines
GB201108986D0 (en) Vaccines
GB201121647D0 (en) Vaccine
GB201108256D0 (en) Vaccine

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed